Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 21;62(8):528-530.
doi: 10.1136/jmg-2025-110696.

Contemporary practice and resource availability for genetic testing in paediatric hypertrophic cardiomyopathy

Collaborators, Affiliations

Contemporary practice and resource availability for genetic testing in paediatric hypertrophic cardiomyopathy

Christoph Sandmann et al. J Med Genet. .
No abstract available

Keywords: Cardiomyopathies; Genetic Diseases, Inborn; Genetic Testing; Genetics, Medical; Pediatrics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. (A) Global map showing the distribution of responding centres (orange). Created with mapchart.net. The centres were located in Spain (n=6), UK (n=6), Italy (n=3), Romania (n=3), Australia (n=2), France (n=2), Germany (n=2), Japan (n=2), Poland (n=2), Argentina (n=1), Finland (n=1), Greece (n=1), Malta (n=1), Norway (n=1), unknown (n=1). (B) Bar graph showing the summary of the reported number of HCM patients seen per year for each centre. (C) Frequency chart showing the changes in the frequency of genetic testing in children with HCM after the recent guideline adjustments in the IPHCC centres. (D) Frequency chart of centres offering routine genetic testing to paediatric HCM patients. (E) Pie chart indicating the clinical specialty of the attending physician performing the genetic testing. (F) Frequency chart showing how many centres offer routine genetic counselling prior to genetic testing for paediatric HCM. (G) Frequency of genetic testing types offered by IPHCC centres for paediatric HCM. (H) Panel sizes used for panel sequencing in paediatric HCM. (I) Frequency of reported paediatric HCM variants by pathogenicity type across IPHCC centres. HCM, hypertrophic cardiomyopathy; IPHCC, International Paediatric Hypertrophic Cardiomyopathy Consortium.

References

    1. Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44:3503–626. doi: 10.1093/eurheartj/ehad194. - DOI - PubMed
    1. Ommen SR, Ho CY, Asif IM, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1239–311. doi: 10.1161/CIR.0000000000001250. - DOI - PubMed
    1. Castrichini M, De Luca A, De Angelis G, et al. Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies. J Am Coll Cardiol. 2024;83:1841–51. doi: 10.1016/j.jacc.2024.02.041. - DOI - PMC - PubMed
    1. Norrish G, Ding T, Field E, et al. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids) JAMA Cardiol. 2019;4:918–27. doi: 10.1001/jamacardio.2019.2861. - DOI - PMC - PubMed
    1. Lopes LR, Ho CY, Elliott PM. Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice. Eur Heart J. 2024;45:2727–34. doi: 10.1093/eurheartj/ehae421. - DOI - PMC - PubMed

LinkOut - more resources